Literature DB >> 1159621

Elimination kinetics of sulfadiazine in patients with normal and impaired renal function.

E E Ohnhaus, P Spring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1159621     DOI： 10.1007/bf01067906

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  12 in total

1.  [On the protein-binding of sulfanilamide in vitro and in vivo].

Authors:  L DETTLI; M BAUR; P SPRING
Journal:  Chemotherapia (Basel)       Date:  1963

2.  The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis".

Authors:  N S BRICKER; P A MORRIN; S W KIME
Journal:  Am J Med       Date:  1960-01       Impact factor: 4.965

3.  Non-ionic diffusion and the excretion of weak acids and bases.

Authors:  M D MILNE; B H SCRIBNER; M A CRAWFORD
Journal:  Am J Med       Date:  1958-05       Impact factor: 4.965

4.  Individualization of drug dosage in patients with renal disease.

Authors:  L Dettli
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

5.  Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function.

Authors:  J Rieder; D E Schwartz; M Fernex; T Bergan; E K Brodwall; A Blumberg; P Cottier; W Scheitlin
Journal:  Antibiot Chemother (1971)       Date:  1974

6.  Studies on the physiological availability and metabolism of sulfonamides. I. Sulfadiazine.

Authors:  G R Van Petten; G C Becking; R J Withey; H F Lettau
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Jan-Feb

7.  [Serum creatinine determination without protein precipitation].

Authors:  H Bartels; M Böhmer; C Heierli
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

8.  Drug dosage in patients with impaired renal function.

Authors:  L Dettli; P Spring; R Habersang
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

9.  Diurnal variations in the elimination rate of a sulfonamide in man.

Authors:  L Dettli; P Spring
Journal:  Helv Med Acta       Date:  1967-01

10.  [Binding of some sulfanilamides to blood proteins of man. 1. Determinations of low sulfanilamide concentrations in vitro at room temperature].

Authors:  P Spring
Journal:  Arzneimittelforschung       Date:  1966-03
View more
  5 in total

1.  Pharmacokinetics of sulfadiazine and trimethoprim in man.

Authors:  F Andreasen; L Elsborg; S Husted; O Thomsen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

2.  Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.

Authors:  J Aarbakke; O Opshaug; A Digranes; A Høylandskjaer; G Fluge; H Fellner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim.

Authors:  B Ekström; U Forsgren; B Ortengren; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 4.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.

Authors:  B Ortengren; L Magni; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.